Please ensure Javascript is enabled for purposes of website accessibility

What's Pushing Up TransEnterix Inc. Stock Today?

By Cory Renauer - Updated Feb 26, 2018 at 3:14PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite a lack of significant news, investors flocked towards the fledgling robotic surgery stock on Monday.

What happened

Shares of TreansEnterix Inc. (ASXC -4.79%), a medical device maker focused on robotic surgery, surged on some above-average volume on Monday. The company has been quiet since a well-received presentation earlier this month, but that didn't stop the stock from rising 14.3% as of 2:43 p.m. EST on Monday. 

So what 

TransEnterix stock has been on a roller coaster ride since the FDA cleared the Senhance System for sale, and it's still prone to erratic price swings. Although the company's path to success is visible, it's taking baby steps.

Hand drawing an upward sloping chart.

Image source: Getty Images.

The system is currently cleared for laparoscopic colorectal surgery and laparoscopic gynecologic surgery, two procedures performed around 1.5 million times each year in the U.S. alone. Despite plenty of potential, TransEnterix's phone isn't ringing off the hook with calls from U.S. hospitals. The company has sold just two Senhance Systems this year, and neither was for a North American hospital.

Now what

It's still too early to be completely dismayed by a lack of new system sales in the U.S., but TransEnterix had better step up its game soon. The company exited last September with just $24.5 million in cash and cash equivalents after operations burned through $69.2 million during the first nine months of the year.

The company intends to report 2017 results after the market closes on March 6, 2018. Today's gains will be awfully short-lived if the company can't show investors any signs of life from the vital U.S. segment.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Asensus Surgical, Inc. Stock Quote
Asensus Surgical, Inc.
ASXC
$0.40 (-4.79%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
317%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/30/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.